SBI Securities’s Definium Therapeutics DFTX Stock Holding History

SBI Securities’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33K	Buy	701 +603	+615%	+$14.9K	﹤0.01%	1333
2026 Q1	$1.85K	Buy	98 +7	+8%	+$119	﹤0.01%	2445
2025 Q4	$1.22K	Sell	91 -14	-13%	-$173	﹤0.01%	2571
2025 Q3	$1.24K	Sell	105 -277	-73%	-$2.58K	﹤0.01%	2606
2025 Q2	$2.48K	Buy	382 +76	+25%	+$500	﹤0.01%	2300
2025 Q1	$1.79K	Buy	306 +110	+56%	+$788	﹤0.01%	2340
2024 Q4	$1.36K	Buy	+196	New	+$1.35K	﹤0.01%	2471

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

SBI Securities's DFTX Position: Q2 2026 in Review

SBI Securities increased its Definium Therapeutics (DFTX) stake by 615% in Q2 2026, buying an estimated $14.9K and bringing the position to 701 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #1333.

SBI Securities first reported a position in DFTX in Q4 2024 and has held it in 7 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

SBI Securities held 701 shares of Definium Therapeutics worth $33K as of Q2 2026.
SBI Securities bought 603 Definium Therapeutics shares in Q2 2026, an estimated $14.9K.
Definium Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1333 holding.
SBI Securities first reported a position in Definium Therapeutics in Q4 2024 and has held it in 7 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.